CHRISTA COOPER: Open Payments
NPI 1831440254 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$30,998 in 62 payments from 6 companies in 2025. Trend: 2023 $3,898 · 2024 $603 · 2025 $30,998
Speaker / faculty: $13,297Consulting: $7,790Travel & lodging: $6,508Speaker / faculty: $2,500Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 18 | $12,867 |
| Teva Pharmaceuticals USA, Inc. | 16 | $11,744 |
| Abbott Laboratories | 24 | $5,850 |
| MDD US Operations, LLC | 2 | $500 |
| Medtronic, Inc. | 1 | $20 |
| Cala Health, Inc. | 1 | $17 |
Products named: INGREZZA, AUSTEDO XR, INFINITY, PROCLAIM, PERCEPT PC BRAINSENSE, Cala kIQ.
Industry payments across IL — which companies pay providers there.
